P425 Biosimilar infliximab in real-life Crohn's disease treatment in anti-TNF-alpha naïve and non-naïve patients in comparison to biologic originator: a comparative observational cohort study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.